Marshall Wace
CLMT icon

Marshall Wace’s Calumet Specialty Products CLMT Stock Holding History

Marshall Wace’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Sell
617,138
-206,890
-25% -$6.95M 0.02% 676
2026
Q1 		$29.6M Buy
824,028
+56,198
+7% +$1.45M 0.03% 555
2025
Q4 		$15.3M Sell
767,830
-123,560
-14% -$2.38M 0.01% 730
2025
Q3 		$16.3M Buy
891,390
+234,766
+36% +$3.86M 0.02% 745
2025
Q2 		$10.3M Sell
656,624
-297,905
-31% -$3.79M 0.01% 827
2025
Q1 		$12.1M Buy
954,529
+634,505
+198% +$9.97M 0.02% 701
2024
Q4 		$7.05M Buy
+320,024
New +$6.73M 0.01% 924
2019
Q4 		– Sell
-7,455
Closed -$27K – 1734
2019
Q3 		$27K Buy
+7,455
New +$31.9K ﹤0.01% 1583
2016
Q1 		– Sell
-209,614
Closed -$4.17M – 1044
2015
Q4 		$4.17M Buy
+209,614
New +$5.18M 0.04% 416
2015
Q3 		– Sell
-119,691
Closed -$3.05M – 932
2015
Q2 		$3.05M Buy
+119,691
New +$3.17M 0.04% 387
2013
Q2 		$6.5M Buy
+178,772
New +$6.43M 0.39% 50

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace's CLMT Position: Q2 2026 in Review

Marshall Wace reduced its Calumet Specialty Products (CLMT) stake by 25% in Q2 2026, selling an estimated $6.95M and leaving 617,138 shares worth $22.2M. The position accounts for 0.02% of the portfolio, ranked #676.

Marshall Wace first reported a position in CLMT in Q2 2013 and has held it in 11 quarters since. The position peaked at $29.6M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Marshall Wace held 617,138 shares of Calumet Specialty Products worth $22.2M as of Q2 2026.
  • Marshall Wace sold 206,890 Calumet Specialty Products shares in Q2 2026, an estimated $6.95M.
  • Calumet Specialty Products made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #676 holding.
  • Marshall Wace first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 11 quarters since.
  • Marshall Wace's Calumet Specialty Products position peaked at $29.6M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.